Name of Patient F. S. Age 35 y.

o Height 5’3
Diagnosis G3P3 (3003) PU del. ceph. term live birth by 1oLSTCS + Sex Female Weight 60 kg
BTL w/ variable deaceration; severe preeclampsia
Author M. M. Olmillo Website milkv.co.vu A/N you’re welcome J
NURSING
MECHANISM OF CONTRAINDICATI ADVERSE
DRUG DATA CLASSIFICATION ACTION
INDICATIONS RESPONSIBILITIE
ON EFFECTS
S
Generic Name: Pharmacologic: Acts directly on General: Contraindicated with CNS: headace, Before:
Hydralazine Hcl Peripheral vascular smooth > oral: essential hypersensitivity to peripheral neuritis, > check doctor’s order
vasodilator muscle to cause hypertension hydralazine, tartrazine; dizziness > wash hands before administering
vasodilation, primarily alone or in CAD, mitral valvular the drug
Trade name/s: arteriolar, decreasing combination with rheumatic heart disease CV: palpitations, > take the client’s BP
Apresoline peripheral resistance; other drugs (implicated in MI) tachycardia, > check the patency of the IV line
maintains or increases > parenteral: angina pectoris > educate the client about the
renal and cerebral severe essential purpose and importance of the drug
Patient’s dose: blood flow hypertension GI: anorexia,
50mg q15mins. x Therapeutic: when drug cannot Precaution: nausea, vomiting,
2 doses for BP Antihypertensive be given orally or Use cautiously with diarrhea
≥ 140/100
when need to CVAs, increased ICP, During:
lower BP is urgent severe hypertension with GU: difficult > Give drug exactly as prescribed
>unlabeled uses: uremia, advanced renal micturation, > Take with food
reducing afterload damage, lactation, impotence > discontinue if blood dyscrasias
Maximum dose: Onset: in the treatment of pregnancy, pulmonary > withdraw drug gradually and not at
800mg repeated Pregnancy Category Rapid heart failure, hypertension Hematologic: blood once
as necessary Risk: C severe aortic dyscrasias > repeat the purpose of the drug
Peak: insufficiency, and
10-20mins after valve Hypersensitivity:
Minimum dose: replacement rash, urticaria,
5-10mg Duration: (doses up to pruritus After:
2-4 hrs 800mg TID) Interactions: > Monitor client for orthostatic
> drug-drug: increased hypertension
Available forms: Metabolism: pharmacologic effect of Other: nasal > reevaluate therapy if patient
Tablets – 10, 25, Hepatic, 3-7 hr beta-adrenergic blockers congestion, develops arthralgia, fever, chest pain,
50, 100mg; Patient’s actual > drug-food: increased flushing, edema, or continued malaise.
injection – Distribution: crosses indication: bioavailability of oral muscle cramps > report persistent or severe
20mg/mL placenta, may enter Pregnancy- hydralazine given with constipation
breast milk induced food > report unexplained fever or
hypertension malaise, muscle or joint aching, rash,
Route: IVTT Excretion: urine numbness, tingling
> document and record.

Source: 2011 Source: 2011 Source: 2011 Source: 2011 Source: 2011 Source: 2011 Source: 2011 Lippincott’s Nursing
Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG Drug Guide